Article History
First Online: 6 August 2020
Compliance with Ethical Standards
:
: JPW and DJL report support from Acorda pharmaceuticals with study medication only for a trial of dalfampridine in primary lateral sclerosis. No other potential conflicts of interest relevant to this article are reported.